Primary care physicians' knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition

被引:79
作者
Escher, M
Sappino, AP
机构
[1] Univ Hosp Geneva, Div Clin Pharmacol, Pain & Palliat Care Consultat, CH-1211 Geneva 14, Switzerland
[2] Univ Hosp Geneva, Dept Internal Med, Div Oncol, Geneva, Switzerland
关键词
attitudes; breast neoplasms; genetic predisposition testing; genetic screening; knowledge; ovarian neoplasms; physician's role; practice;
D O I
10.1023/A:1008319114278
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Primary health care providers are expected to be directly involved in the genetic testing for cancer susceptibility. This study assessed physicians' knowledge, attitude and perception of their role towards testing for hereditary breast-ovarian cancer. Design: A mail-in survey was sent to all general practitioners, internists, obstetrician-gynecologists and oncologists in private practice in Geneva county, Switzerland. Questions included socio-demographic variables, knowledge about hereditary breast-ovarian cancer, attitude towards testing and assessment of their role in the pre- and post-test procedure. Results: Two hundred fifty-nine (65%) of four hundred questionnaires were returned of which two hundred forty-three (61%) were analysed. Response rates were similar between specialties; women answered more frequently. The majority of the respondents (87%) approved of genetic susceptibility testing. The most common objection to testing was the absence of approved strategies for the prevention and detection of early breast cancer. Most physicians felt they had an active part to play in the pre-test procedure, the disclosure of results, and especially the consultants' long-term care and support (99%). Physicians correctly answered a third (32%) of the knowledge questions. The abstention rate for individual items ranged from 13% to 60%. Scores varied by specialty. Oncologists were more knowledgeable than gynecologists, internists and general practitioners. Conclusions: The majority of the primary care physicians in this study have a favourable attitude and are ready to play a prominent role in genetic counseling and testing for breast-ovarian cancer predisposition. Defective knowledge scores, however, underline the need for targeted educational programs.
引用
收藏
页码:1131 / 1135
页数:5
相关论文
共 38 条
[31]  
2-X
[32]   ATTITUDES OF DUTCH GENERAL-PRACTITIONERS TOWARDS PRESYMPTOMATIC DNA-TESTING FOR HUNTINGTON DISEASE [J].
THOMASSEN, R ;
TIBBEN, A ;
NIERMEIJER, MF ;
VANDERDOES, E ;
VANDEKAMP, JJP ;
VERHAGE, F .
CLINICAL GENETICS, 1993, 43 (02) :63-68
[33]  
Vennin P, 1996, B CANCER, V83, P697
[34]   The 'new genetics' and primary care: GPs' views on their role and their educational needs [J].
Watson, EK ;
Shickle, D ;
Qureshi, N ;
Emery, J ;
Austoker, J .
FAMILY PRACTICE, 1999, 16 (04) :420-425
[35]  
Weber R, 1996, AM FAM PHYSICIAN, V53, P1976
[36]   LOCALIZATION OF A BREAST-CANCER SUSCEPTIBILITY GENE, BRCA2, TO CHROMOSOME 13Q12-13 [J].
WOOSTER, R ;
NEUHAUSEN, SL ;
MANGION, J ;
QUIRK, Y ;
FORD, D ;
COLLINS, N ;
NGUYEN, K ;
SEAL, S ;
TRAN, T ;
AVERILL, D ;
FIELDS, P ;
MARSHALL, G ;
NAROD, S ;
LENOIR, GM ;
LYNCH, H ;
FEUNTEUN, J ;
DEVILEE, P ;
CORNELISSE, CJ ;
MENKO, FH ;
DALY, PA ;
ORMISTON, W ;
MCMANUS, R ;
PYE, C ;
LEWIS, CM ;
CANNONALBRIGHT, LA ;
PETO, J ;
PONDER, BAJ ;
SKOLNICK, MH ;
EASTON, DF ;
GOLDGAR, DE ;
STRATTON, MR .
SCIENCE, 1994, 265 (5181) :2088-2090
[37]   IDENTIFICATION OF THE BREAST-CANCER SUSCEPTIBILITY GENE BRCA2 [J].
WOOSTER, R ;
BIGNELL, G ;
LANCASTER, J ;
SWIFT, S ;
SEAL, S ;
MANGION, J ;
COLLINS, N ;
GREGORY, S ;
GUMBS, C ;
MICKLEM, G ;
BARFOOT, R ;
HAMOUDI, R ;
PATEL, S ;
RICE, C ;
BIGGS, P ;
HASHIM, Y ;
SMITH, A ;
CONNOR, F ;
ARASON, A ;
GUDMUNDSSON, J ;
FICENEC, D ;
KELSELL, D ;
FORD, D ;
TONIN, P ;
BISHOP, DT ;
SPURR, NK ;
PONDER, BAJ ;
EELES, R ;
PETO, J ;
DEVILEE, P ;
CORNELISSE, C ;
LYNCH, H ;
NAROD, S ;
LENOIR, G ;
EGILSSON, V ;
BARKADOTTIR, RB ;
EASTON, DF ;
BENTLEY, DR ;
FUTREAL, PA ;
ASHWORTH, A ;
STRATTON, MR .
NATURE, 1995, 378 (6559) :789-792
[38]  
Worthen HG, 1999, CANCER-AM CANCER SOC, V86, P1763